Factors governing P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier measured with positron emission tomography

Thomas Wanek; Kerstin Römermann; Severin Mairinger; Johann Stanek; Michael Sauberer; Thomas Filip; Alexander Traxl; Claudia Kuntner; Jens Pahnke; F Bauer; T Erker; Wolfgang Löscher; M Müller; Oliver Langer

Factors governing P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier measured with positron emission tomography

Thomas Wanek, Kerstin Römermann, Severin Mairinger, Johann Stanek, Michael Sauberer, Thomas Filip, Alexander Traxl, Claudia Kuntner, Jens Pahnke, F Bauer, T Erker, Wolfgang Löscher, M Müller, Oliver Langer

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	3214-3225
Seitenumfang	12
Fachzeitschrift	Molecular Pharmaceutics
Publikationsstatus	Veröffentlicht - 2015

Research Field

Ehemaliges Research Field - Health and Bioresources

Diese Publikation zitieren

@article{da1a8da3705c4d019d8fd56a65c3bf89,

title = "Factors governing P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier measured with positron emission tomography",

author = "Thomas Wanek and Kerstin R{\"o}mermann and Severin Mairinger and Johann Stanek and Michael Sauberer and Thomas Filip and Alexander Traxl and Claudia Kuntner and Jens Pahnke and F Bauer and T Erker and Wolfgang L{\"o}scher and M M{\"u}ller and Oliver Langer",

year = "2015",

language = "English",

pages = "3214--3225",

journal = "Molecular Pharmaceutics",

issn = "1543-8384",

publisher = "American Chemical Society",

}

TY - JOUR

T1 - Factors governing P-glycoprotein-mediated drug-drug interactions at the blood-brain barrier measured with positron emission tomography

AU - Wanek, Thomas

AU - Römermann, Kerstin

AU - Mairinger, Severin

AU - Stanek, Johann

AU - Sauberer, Michael

AU - Filip, Thomas

AU - Traxl, Alexander

AU - Kuntner, Claudia

AU - Pahnke, Jens

AU - Bauer, F

AU - Erker, T

AU - Löscher, Wolfgang

AU - Müller, M

AU - Langer, Oliver

PY - 2015

Y1 - 2015

M3 - Article

SN - 1543-8384

SP - 3214

EP - 3225

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

ER -